Alpha Tau Medical Q1 EPS $(0.11) Beats $(0.12) Estimate
Portfolio Pulse from Benzinga Newsdesk
Alpha Tau Medical (NASDAQ:DRTS) reported a Q1 EPS of $(0.11), beating the analyst estimate of $(0.12) by 8.33%. This represents an 8.33% improvement over the same period last year.
May 20, 2024 | 8:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpha Tau Medical reported a Q1 EPS of $(0.11), beating the analyst estimate of $(0.12) by 8.33%. This improvement over the same period last year is likely to positively impact the stock price in the short term.
Beating analyst estimates typically has a positive impact on stock prices. The 8.33% improvement over the same period last year further supports a positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100